170 related articles for article (PubMed ID: 17371294)
1. Expression of human tissue plasminogen activator in the trypanosomatid protozoan Leishmania tarentolae.
Soleimani M; Mahboudi F; Davoudi N; Amanzadeh A; Azizi M; Adeli A; Rastegar H; Barkhordari F; Mohajer-Maghari B
Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):55-61. PubMed ID: 17371294
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of recombinant human tissue plasminogen activator in Leishmania tarentolae.
Hemayatkar M; Mahboudi F; Majidzadeh-A K; Davami F; Vaziri B; Barkhordari F; Adeli A; Mahdian R; Davoudi N
Biotechnol J; 2010 Nov; 5(11):1198-206. PubMed ID: 21058320
[TBL] [Abstract][Full Text] [Related]
3. Recombinant protein expression in Leishmania tarentolae.
Basile G; Peticca M
Mol Biotechnol; 2009 Nov; 43(3):273-8. PubMed ID: 19779853
[TBL] [Abstract][Full Text] [Related]
4. Cloning and expression of truncated form of tissue plasminogen activator in Leishmania tarentolae.
Nazari R; Davoudi N
Biotechnol Lett; 2011 Mar; 33(3):503-8. PubMed ID: 21120587
[TBL] [Abstract][Full Text] [Related]
5. Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review.
Niimi T
Methods Mol Biol; 2012; 824():307-15. PubMed ID: 22160905
[TBL] [Abstract][Full Text] [Related]
6. Isotopic labeling of recombinant proteins expressed in the protozoan host Leishmania tarentolae.
Niculae A; Bayer P; Cirstea I; Bergbrede T; Pietrucha R; Gruen M; Breitling R; Alexandrov K
Protein Expr Purif; 2006 Aug; 48(2):167-72. PubMed ID: 16740394
[TBL] [Abstract][Full Text] [Related]
7. Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae.
Kushnir S; Gase K; Breitling R; Alexandrov K
Protein Expr Purif; 2005 Jul; 42(1):37-46. PubMed ID: 15939291
[TBL] [Abstract][Full Text] [Related]
8. Maxicircle (mitochondrial) genome sequence (partial) of Leishmania major: gene content, arrangement and composition compared with Leishmania tarentolae.
Yatawara L; Le TH; Wickramasinghe S; Agatsuma T
Gene; 2008 Nov; 424(1-2):80-6. PubMed ID: 18718512
[TBL] [Abstract][Full Text] [Related]
9. Comparative expression of wild-type and highly soluble mutant His103Leu of hydroxynitrile lyase from Manihot esculenta in prokaryotic and eukaryotic expression systems.
Dadashipour M; Fukuta Y; Asano Y
Protein Expr Purif; 2011 May; 77(1):92-7. PubMed ID: 21185385
[TBL] [Abstract][Full Text] [Related]
10. The production of recombinant human laminin-332 in a Leishmania tarentolae expression system.
Phan HP; Sugino M; Niimi T
Protein Expr Purif; 2009 Nov; 68(1):79-84. PubMed ID: 19607924
[TBL] [Abstract][Full Text] [Related]
11. Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae.
Kushnir S; Cirstea IC; Basiliya L; Lupilova N; Breitling R; Alexandrov K
Mol Biochem Parasitol; 2011 Apr; 176(2):69-79. PubMed ID: 21167214
[TBL] [Abstract][Full Text] [Related]
12. Expression of multisubunit proteins in Leishmania tarentolae.
Sugino M; Niimi T
Methods Mol Biol; 2012; 824():317-25. PubMed ID: 22160906
[TBL] [Abstract][Full Text] [Related]
13. Transformed Lepidopteran insect cells: new sources of recombinant human tissue plasminogen activator.
Farrell PJ; Behie LA; Iatrou K
Biotechnol Bioeng; 1999 Aug; 64(4):426-33. PubMed ID: 10397881
[TBL] [Abstract][Full Text] [Related]
14. Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae.
Azizi H; Hassani K; Taslimi Y; Najafabadi HS; Papadopoulou B; Rafati S
Parasitology; 2009 Jun; 136(7):723-35. PubMed ID: 19416551
[TBL] [Abstract][Full Text] [Related]
15. Construction and analysis of Leishmania tarentolae transgenic strains free of selection markers.
Mureev S; Kushnir S; Kolesnikov AA; Breitling R; Alexandrov K
Mol Biochem Parasitol; 2007 Oct; 155(2):71-83. PubMed ID: 17658188
[TBL] [Abstract][Full Text] [Related]
16. Leishmania tarentolae for the Production of Multi-subunit Complexes.
Niimi T
Adv Exp Med Biol; 2016; 896():155-65. PubMed ID: 27165324
[TBL] [Abstract][Full Text] [Related]
17. Potential application of Leishmania tarentolae as an alternative platform for antibody expression.
Lai JY; Klatt S; Lim TS
Crit Rev Biotechnol; 2019 May; 39(3):380-394. PubMed ID: 30720351
[TBL] [Abstract][Full Text] [Related]
18. Expression of human c-reactive protein in different systems and its purification from Leishmania tarentolae.
Dortay H; Schmöckel SM; Fettke J; Mueller-Roeber B
Protein Expr Purif; 2011 Jul; 78(1):55-60. PubMed ID: 21440634
[TBL] [Abstract][Full Text] [Related]
19. Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli.
Long X; Gou Y; Luo M; Zhang S; Zhang H; Bai L; Wu S; He Q; Chen K; Huang A; Zhou J; Wang D
BMC Biotechnol; 2015 Mar; 15():13. PubMed ID: 25886739
[TBL] [Abstract][Full Text] [Related]
20. Exploiting Leishmania tarentolae cell-free extracts for the synthesis of human solute carriers.
Ruehrer S; Michel H
Mol Membr Biol; 2013 Jul; 30(4):288-302. PubMed ID: 23802133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
